简介
GIUSEPPE REMUZZI, M.D., F.R.C.P.
Director, Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Prof. Giuseppe Remuzzi was born in Bergamo, Italy in 1949. Upon completion of his medical training at the University of Pavia in 1974, he received specialty training in Hematology and Nephrology at the University of Milan. Since 1975 he has pursued an academic career at Bergamo’s Papa Giovanni XXIII hospital, where he was appointed Director of the Department of Medicine and Transplantation (1996-2013), Director of the Department of Immunology and Transplant Medicine (2004) and, from 2011 until 2015, Director of the Department of Medicine. He has also been Head of the Division of Nephrology and Dialysis at the same hospital (1999-2018). In June 2015 he was nominated Chiara Fama Professor of Nephrology at the University of Milan.
From 1984 to 2018 he also coordinated the Negri Bergamo Laboratories of the “Mario Negri” Institute for Pharmacological Research and the affiliated Clinical Research Center for Rare Diseases “Aldo e Cele Daccò” in Ranica (BG), a group of basic scientists, physiologists, pharmacologists, molecular and cellular biologists, pathologists and clinicians devoted to the study of human renal diseases and their corresponding animal models from the perspective of pathophysiology and therapeutic intervention. He touched major advances in many areas of nephrology. For example, his studies have led to new insights into many disorders, including the interactions between platelets and endothelium, pathophysiology of glomerular diseases and the factors that influence the progressive loss of kidney function. Work focused on improving the outlook for patients with end stage renal disease. Giuseppe Remuzzi pays tribute to the work of pioneers such as Barry Brenner, who delved deep into the processes behind glomerular function and their possible reversibility. Early work on the use of angiotensin-converting enzyme inhibitors to slow the decline of glomerular filtration rates proved dialysis was avoidable, not inevitable. Studies on immunologic mechanisms that influence the survival of transplanted organs, understanding of immunologic tolerance in the disorders that are linked to autoimmunity and finally, genetic diseases of the kidney have also been areas of investigation. Concerned by kidney donation shortages and deploring the current practice of discarding suboptimal donor kidneys, his team has shown that transplanting such kidneys in pairs is feasible and have set up an international effort to validate this approach. Giuseppe Remuzzi is investigating the kidney's ability to regenerate itself.
Prof. Remuzzi serves on editorial boards of numerous journals and is member of the International Advisory Board of The Lancet. He served as Editorial Board member of the New England Journal of Medicine from 1998 to 2013. In recognition of his achievements, he has been awarded in 1998 honorary memberships of the Association of American Physicians and the British Royal College of Physicians. In 2001 he was nominated Chairman of the Research and Prevention Committee of the COMGAN (Commission on Global Advancement of Nephrology) of the International Society of Nephrology (ISN). In 2005 during the World Congress of Nephrology in Singapore he received the ISN Jean Hamburger Award. In 2006 he was invited by the Italian Health Minister to become member of the Commission: “Consiglio Superiore di Sanità”. In 2007 he received during the annual American Society of Nephrology Congress in San Francisco the prestigious ASN John P. Peters Award and in 2011 he was awarded with the ISN AMGEN Award (WCN 2011, Vancouver). In November 2011, he received the Third Edition of the International Award "Luis Hernando" assigned by the Iñigo Alvarez de Toledo Renal Foundation (FRIAT) in Madrid, Spain. From June 2013 until March 2015 he was President of the International Society of Nephrology (ISN), and he was the creator of the global ISN initiative called 0 by 25: Nobody should die of preventable and treatable Acute Kidney Injury (AKI) by 2025. In 2018 he received the Award “Lennox K. Black International Prize for Excellence in medicine”, Philadelphia, USA.
Prof. Remuzzi has authored and co-authored more than 1450 scientific articles, reviews and monographs, and regularly collaborates on scientific articles with the Italian national newspaper Corriere della Sera.
